New strategy to boost the effect of immunotherapy in the most aggressive form of lung cancer
Peer-Reviewed Publication
Updates every hour. Last Updated: 12-Aug-2025 06:12 ET (12-Aug-2025 10:12 GMT/UTC)
Inhibiting a specific gene, MET, in combination with standard chemotherapy and immunotherapy, enhances treatment efficacy and limits tumor growth in small cell lung cancer (SCLC). The study, led by the Hospital del Mar Research Institute, analyzed the effect of MET inhibition in mouse models and studied gene expression in patient tumor samples. The results are published in Cell Reports Medicine. Researchers aim to pursue this line of research with a clinical trial involving patients.
They’ve survived for billions of years in boiling acid, deep-sea vents and salt flats. Now, some of Earth’s oldest life forms — microbes called Archaea — are offering a new weapon in the fight against one of today’s most urgent health threats: antibiotic resistance. In a new study published in Nature Microbiology, researchers at the University of Pennsylvania used artificial intelligence to identify previously unknown compounds in Archaea that could fuel the development of next-generation antibiotics.
Scientists at Tsinghua University have developed a method to grow kidney tumours in the lab using cells from real patients, offering a potential new tool in the fight against renal cancer. Their research, published in the journal Biofabrication, outlines how 3D bioprinting technology can be used to replicate the unique characteristics of each patient’s tumour.
A new national survey conducted by Ipsos on behalf of The Kids Mental Health Foundation, founded by Nationwide Children’s Hospital, reveals nearly a third of parents (30%) whose child missed school due to fear or anxiety last year report their child missed more than a week of school.